Is there a role for digoxin in the management of acute aluminum phosphide poisoning?

Medical Hypotheses

Volumn 76, Issue 5, 2011, Pages 765-766

  Sanaei Zadeh, Hossein ^a   Farajidana, Hoorvash ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM PHOSPHIDE; DIGOXIN;

DIGITALIZATION; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART RATE; HUMAN; INTOXICATION; LETTER;

ADMINISTRATION, ORAL; ALUMINUM COMPOUNDS; ANIMALS; DIGOXIN; ELECTROCARDIOGRAPHY; ENZYME INHIBITORS; FREE RADICALS; HEART RATE; HUMANS; MODELS, BIOLOGICAL; MODELS, THEORETICAL; PHOSPHINES; RATS; RODENTICIDES;

EID: 79954414951     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.02.023     Document Type: Letter

References (13)

1. International Program in Chemical Safety (IPCS). World Health Organization. ; 2007 [accessed 3.8.2007]. http://www.inchem.org.
2. Siwach S.B., Gupta A. The profile of acute poisonings in Haryana-Rohtak study. J Assoc Physicians India 1995, 43(11):756-759.
3. Singh S., Wig N., Chaudhary D., Sood N.K., Sharma B.K. Changing pattern of acute poisoning in adults: experience of a large North-west Indian Hospital (1970-1989). J Assoc Physicians India 1997, 45(3):194-197.
4. Chefurka W., Kashi K.P., Bond E.J. The effect of phosphine on electron transport in mitochondria. Pestic Biochem Physiol 1976, 6:65-84.
5. Mittra S., Peshin S.S., Lall S.B. Cholinesterase inhibition by aluminium phosphide poisoning in rats and effects of atropine and pralidoxime chloride. Acta Pharmacologica Sinica 2001, 22(1):37-39.
6. Goswami M., Bindal M., Sen P., Gupta S.K., Avasthi R., Ram B.K. Fat and oil inhibit phosphine release from aluminium phosphide - its clinical implication. Indian J Exp Biol 1994, 32(9):647-649.
7. Azad A., Lall S.B., Mittra S. Effect of N-acetylcysteine and L-NAME on aluminium phosphide induced cardiovascular toxicity in rats. Acta Pharmacol Sin 2001, 22:298-304.
8. Chugh S.N., Kamar P., Sharma A., Chugh K., Mittal A., Arora B. Magnesium status and parenteral magnesium sulphate therapy in acute aluminum phosphide intoxication. Magnesium Res: Official Organ Int Soc Dev Res Magnesium 1994, 7(3-4):289-294.
9. Duenas A., Perez-Castrillon J.L., Cobos M.A., et al. Treatment of the cardiovascular manifestations of phosphine poisoning with trimetazidine, a new anti-ischemic drug. Am J Emerg Med 1999, 17:219-220.
10. Chugh S.N., Chugh K., Ram S., Malhotra K.C. Electrocardiographic abnormalities in aluminium phosphide poisoning with special reference to its incidence, pathogenesis, mortality and histopathology. J Indian Med Assoc 1991, 89(2):32-35.
11. Akkaoui M., Achour S., Abidi K., Himdi B., Madani A., Zeggwagh A.A., et al. Reversible myocardial injury associated with aluminum phosphide poisoning. Clin Toxicol 2007, 45(6):728-731.
12. Gupta MS, Malik A, Sharma VK. Cardiovascular manifestations in aluminium phosphide poisoning with special reference to echocardiographic changes. J Assoc Phys India 1995;43(11):773-4 and 779-80.
13. Gheorghiade M., Hall V., Lakier J., et al. Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure. J Am Coll Cardiol 1989, 13:134-142.